Skip to main content
OpenTrials
Completed

NCT Number: NCT04151004

Functional Muscle Characteristics and Cardio-respiratory Interaction in Patients With Fontan Palliation

Congenital heart disease (CHD) is the most common congenital defect, affecting about 1% of newborns. Among adults surviving complex CHD, the cohort of survivors after the Fontan palliation for univentricular physiology is the most rapidly growing. Given their unique physiology without a pumping chamber supporting the pulmonary circulation, their exercise capacity as adults is often severely reduced. Therefore, patients with grown-up CHD typically need long-term expert medical care causing constantly increasing healthcare- related costs. Specific exercise regimes might offer a safe, efficacious and cost-effective alternative to pharmacologic interventions and surgery. The underlying mechanisms of impaired exercise capacity in Fontan patients are, however, not fully understood and consequently, training regimes specifically tackling the limiting factors cannot be developed. In patients with CHD, studies have suggested that exercise limitations are secondary to the cardiac defects, factors related to cardiac surgery, chronotropic incompetence and underlying lung disease. Similar to heart failure patients, exercise limitations could be traced back to insufficient respiratory and leg muscle functions and impaired cardiovascular regeneration processes possibly due to an altered stem cell number and function in the peripheral blood.

The present study will investigate cardiac, respiratory and quadriceps muscle function at rest and during submaximal and maximal whole-body exercises. A special focus will be given on respiratory and quadriceps muscle strength, and proneness of these muscles to fatigue, which has not yet been objectively investigated. Moreover, different respiratory muscle training (RMT) protocols will be executed, to assess the safety of these interventions. Moreover, the current study will be the first to investigate the influence of exhaustive exercise protocols on the number and function of circulating stem and progenitor cells (CPCs) in Fontan patients. The number of these cell populations was shown to strongly correlate with long-term outcome and recovery in several diseases. This study aims to reveal whether Fontan patients show similarly alternated stem cell number and function in the peripheral blood, that likely result in impaired vascular regeneration processes and possibly also contribute to reduced exercise capacity.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Exercise Physiology Lab, Institute of Human Movement Sciences and Sport, ETH Zurich

Zurich, Canton of Zurich, 8057, Switzerland

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age: 18 - 55 years
  • Fontan palliation (for Fontan patients)
  • NYHA I - III (for Fontan patients)
  • Willing to adhere to the study rules

Exclusion criteria

  • NYHA IV (for Fontan patients)
  • not being able to perform cycle exercise
  • known diaphragmatic paresis
  • being pregnant or breast feeding
  • Intention to become pregnant during the course of the study
  • known or suspected non-compliance, drug or alcohol abuse
  • Regular intake of medication affecting sleep or the performance of the respiratory, cardiovascular or neuromuscular system (except for Fontan-related medication for patients)
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
  • previous enrolment in current study
  • being investigator or his/her family member, employee or another dependent person

Treatment and study plan

Incremental cycling test (ICT)

Other

Incremental cycling test to volitional exhaustion

Constant load cycling test (CET)

Other

Constant load cycling test to volitional exhaustion.

Incremental respiratory muscle test (IncRMET)

Other

Incremental respiratory muscle test to volitional exhaustion.

Incremental quadriceps muscle test (IncQMT)

Other

Incremental quadriceps muscle test to volitional exhaustion.

Respiratory muscle training like interventions

Other

Three different respiratory muscle training like interventions that are usually used for respiratory muscle trainings.

Primary outcomes

  1. Change in respiratory muscle strength (in cmH2O)

    Time frame: At baseline and after acute exercise (approximately 15 minutes)

    Change in respiratory muscle strength will be measured between baseline and after an acute exercise

  2. Change in quadriceps muscle strength (in Newton)

    Time frame: At baseline and after acute exercise (approximately 15 minutes)

    Change in quadriceps muscle strength will be measured between baseline and after an acute exercise

Secondary outcomes

  1. Change in ventilation (in liter per minute)

    Time frame: On visit 1at baseline and after acute exercise (approximately 15 minutes)

    Change in ventilation will be measured between baseline and after an acute exercise

  2. Change in gas exchange (in liter per minute)

    Time frame: At baseline and after acute exercise (approximately 15 minutes)

    Change in gas exchange will be measured between baseline and after an acute exercise

  3. Change in heart rate (beats per minute)

    Time frame: At baseline and after acute exercise (approximately 15 minutes)

    Change in heart rate will be measured between baseline and after an acute exercise

  4. Change in cardiac output (in liter per minute)

    Time frame: At baseline and after acute exercise (approximately 15 minutes)

    Change in cardiac output will be measured between baseline and after an acute exercise

  5. Change in blood pressure (in mmHg)

    Time frame: At baseline and after acute exercise (approximately 15 minutes)

    Change in cardiac output will be measured between baseline and after an acute exercise

  6. Change in blood oxygen saturation (in %)

    Time frame: At baseline and after acute exercise (approximately 15 minutes)

    Change in blood oxygen saturation will be measured between baseline and after an acute exercise

Sponsors and collaborators

Lead sponsor

Swiss Federal Institute of Technology

Other

Registry information

Acronym: FONTANEX

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
Nov 5, 2019
Registry last updated
Oct 26, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.